Versigent (VGNT) CLO Janis Acosta receives two Ordinary Share grants

Rhea-AI Filing Summary

Versigent PLC chief legal officer and secretary Janis N. Acosta reported receiving two equity awards of the company’s Ordinary Shares. On April 22, 2026, she acquired 21,254 Ordinary Shares at $0.00 per share in a grant classified as a “grant, award, or other acquisition.” Following this grant, her reported direct holdings in that line were 39,871 shares.

On the same date, she received a second grant of 18,617 Ordinary Shares, also at $0.00 per share, with that line showing 18,617 shares held directly after the transaction. These transactions are compensation-related share awards rather than open‑market purchases or sales.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Acosta Janis N

Role CLO and Secretary

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	18,617	$0.00	--
Grant/Award	Ordinary Shares	21,254	$0.00	--

Holdings After Transaction: Ordinary Shares — 18,617 shares (Direct, null)

Footnotes (1)

Key Figures

First share grant: 21,254 Ordinary Shares Shares after first grant line: 39,871 shares Second share grant: 18,617 Ordinary Shares +3 more

6 metrics

First share grant 21,254 Ordinary Shares Grant on April 22, 2026 at $0.00 per share

Shares after first grant line 39,871 shares Direct holdings shown following first grant entry

Second share grant 18,617 Ordinary Shares Grant on April 22, 2026 at $0.00 per share

Shares after second grant line 18,617 shares Direct holdings shown following second grant entry

Number of acquisition transactions 2 transactions Both coded A as grant, award, or other acquisition

Transaction date April 22, 2026 Date for both reported Ordinary Shares grants

Key Terms

Ordinary Shares, Grant, award, or other acquisition, Form 4

3 terms

Ordinary Shares financial

"She acquired 21,254 Ordinary Shares at $0.00 per share"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Grant, award, or other acquisition financial

"in a grant classified as a “grant, award, or other acquisition.”"

Form 4 regulatory

"Versigent PLC reported that ... on Form 4"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Acosta Janis N

(Last) (First) (Middle)

SPITALSTRASSE 5,

(Street)

8200 SCHAFFHAUSEN SWITZERLAND

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Versigent PLC [ VGNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CLO and Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/22/2026		A		18,617	A	$0.00	18,617	D
Ordinary Shares	04/22/2026		A		21,254	A	$0.00	39,871	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Janis Acosta	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)